InvestmentAppointmentsHealthTech

Digital healthcare solutions provider MyWay Digital Health has raised £3m to accelerate the development of its new AI-enabled products. 

The University of Dundee spinout has secured the funding from private equity firm Foresight Group and will also use the investment to expand its commercial footprint to meet growing global demand for scalable digital health solutions.

The HealthTech, which employs 30 staff across Scotland and England, is looking to improve the lives of individuals living with long-term conditions through cost-effective, data-driven, personalised health technology. 

Its flagship platform, MyWay Diabetes, is a clinically validated digital self-management tool that integrates with NHS systems to provide personalised education, data visualisation and actionable insights for patients and clinicians. 

The platform has been adopted across multiple NHS regions and internationally, demonstrating measurable improvements in patient engagement and health outcomes.

Trailblazing tech law firm opens first international office in London

Dr Umang Patel will also join the business as non-executive chair, bringing extensive experience from the technology and healthcare sectors.

He currently serves as chief clinical information officer for Microsoft in the EMEA region and will work closely with the management team to drive both domestic and international expansion.

“We are delighted to have secured investment from Foresight, marking a significant milestone in MWDH’s journey,” said Debbie Wake, CEO and co-founder of MyWay Digital Health.

“Their support will enable us to accelerate our growth strategy, broaden our product offering, and further expand our global footprint.”

Daniel Halliday, managing director at Foresight Group, added: “The adoption of digital tools and AI to reduce the burden on frontline care is critical. 

“MWDH is at the forefront of this and its best in class technology is proven to deliver better health outcomes and cost savings for its customers. 

“Foresight is excited to support the team on their next phase of growth.”

Former unicorn appoints ex-FTSE 250 exec as new CFO